AMSTERDAM, the Netherlands, Nov. 23, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leader in human gene therapy, today announced that the Company will release its financial results and a corporate update for the third quarter on November 30, 2015. uniQure management will hold a conference call and webcast at 8:30 EST/14:30 CET November 30, 2015, after the press release has been issued to discuss the update. The conference call can be accessed by dialing one of the numbers listed below five minutes prior to the start of the call and providing the confirmation code: 8270401.
The webcast can be accessed through the link displayed in the “Events” section on the “Media” page of the uniQure website at http://www.uniqure.com/news/calendar-of-events/. The webcast replay will be available for at least 72 hours following the call.
Conference Call and Webcast
| Local - Amsterdam, Netherlands: | +31 (0) 20 716 8257 |
| Local - New York, United States of America: | +1 646 254 3365 |
| Local - Berlin, Germany: | +49 (0) 30 3001 90540 |
| Local - London, United Kingdom: | +44 (0) 20 3427 1902 |
| Local - Milan, Italy: | +39 02 3859 1420 |
| Local - Paris, France: | +33 (0) 1 76 77 22 26 |
| Local - Brussels, Belgium: | +32 (0) 2 620 0138 |
| Local - Montreal, Canada: | +1 514 841 2153 |
About uniQure
uniQure is delivering on the promise of gene therapy – single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with CNS, liver/metabolic and cardiovascular diseases. www.uniQure.com
CONTACT: uniQure: Aicha Diba Investor Relations Direct: +31 20 240 6100 Main: +31 20 566 7394 a.diba@uniQure.com Media inquiries: Gretchen Schweitzer MacDougall Biomedical Communications Direct: +49 172 861 8540 Main: +49 89 2424 3494 or +1 781 235 3060 gschweitzer@macbiocom.com
